These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8790306)

  • 1. Drug therapy for Parkinson's disease.
    Charles PD; Davis TL
    South Med J; 1996 Sep; 89(9):851-6. PubMed ID: 8790306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Early treatment of Parkinson's disease with levodopa].
    Odekerken VJ; Post B; Verschuur CV; de Bie RM
    Ned Tijdschr Geneeskd; 2009; 153():A286. PubMed ID: 19785822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Axial hypertonicity in Parkinson's disease: direct measurements of trunk and hip torque.
    Wright WG; Gurfinkel VS; Nutt J; Horak FB; Cordo PJ
    Exp Neurol; 2007 Nov; 208(1):38-46. PubMed ID: 17692315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacological treatment of parkinsonian tremor].
    Yokochi F
    Nihon Rinsho; 2000 Oct; 58(10):2091-5. PubMed ID: 11068452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effectiveness and tolerance of piribedil as adjunct therapy to levodopa in patients with Parkinson's disease: a nine month follow up].
    Salazar Tortolero G; Wix Ramos R; Salazar Aladrén P; Jiménez León JC
    Rev Neurol; 2004 Apr 16-30; 38(8):715-9. PubMed ID: 15122540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying poor symptom control in Parkinson's disease.
    Scott L
    Nurs Times; 2006 Mar 21-27; 102(12):30-2. PubMed ID: 16594560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Motor symptoms in Parkinson disease].
    Larsen JP; Beiske AG; Bekkelund SI; Dietrichs E; Tysnes OB; Vilming ST; Aasly JO
    Tidsskr Nor Laegeforen; 2008 Sep; 128(18):2068-71. PubMed ID: 18846123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors determining when to start levodopa/carbidopa/entacapone treatment in Spanish patients with Parkinson's disease.
    Martínez-Martín P; Hernández B; Ricart J;
    Neurologia; 2014 Apr; 29(3):153-60. PubMed ID: 23465686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of bilateral subthalamic nucleus stimulation on levodopa-unresponsive axial symptoms in Parkinson's disease.
    Yamada K; Goto S; Hamasaki T; Kuratsu JI
    Acta Neurochir (Wien); 2008 Jan; 150(1):15-22; discussion 22. PubMed ID: 18180867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parkinson's disease: emerging pharmacotherapy.
    Strecker K; Schwarz J
    Expert Opin Emerg Drugs; 2008 Dec; 13(4):573-91. PubMed ID: 19046128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parkinson's disease primer.
    Miller JL
    Geriatr Nurs; 2002; 23(2):69-74; quiz 75. PubMed ID: 11956518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of a dihydromorphanthridine derivative in Parkinson's patients treated with L-dopa. A preliminary report.
    Wycis HT
    Confin Neurol; 1972; 34(2):130-5. PubMed ID: 4666056
    [No Abstract]   [Full Text] [Related]  

  • 13. Parkinson's Disease.
    Reich SG; Savitt JM
    Med Clin North Am; 2019 Mar; 103(2):337-350. PubMed ID: 30704685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart rate variability shows different cardiovascular modulation in Parkinson's disease patients with tremor dominant subtype compared to those with akinetic rigid dominant subtype.
    Solla P; Cadeddu C; Cannas A; Deidda M; Mura N; Mercuro G; Marrosu F
    J Neural Transm (Vienna); 2015 Oct; 122(10):1441-6. PubMed ID: 25797035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The long-acting dopamine receptor agonist cabergoline in early Parkinson's disease: final results of a 5-year, double-blind, levodopa-controlled study.
    Bracco F; Battaglia A; Chouza C; Dupont E; Gershanik O; Marti Masso JF; Montastruc JL;
    CNS Drugs; 2004; 18(11):733-46. PubMed ID: 15330687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical management of levodopa-associated motor complications in patients with Parkinson's disease.
    Jankovic J; Stacy M
    CNS Drugs; 2007; 21(8):677-92. PubMed ID: 17630819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Individual manifestations of Parkinson's disease after ten or more years of levodopa.
    Klawans HL
    Mov Disord; 1986; 1(3):187-92. PubMed ID: 3504244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment options for early Parkinson's disease.
    Stacy M; Brownlee HJ
    Am Fam Physician; 1996 Mar; 53(4):1281-7. PubMed ID: 8629572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomly assigned double-blind cross-over study examining the relative anti-parkinsonian tremor effects of pramipexole and pergolide.
    Navan P; Findley LJ; Undy MB; Pearce RK; Bain PG
    Eur J Neurol; 2005 Jan; 12(1):1-8. PubMed ID: 15613140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroleptic-induced parkinsonism and Parkinson's disease: differential diagnosis and treatment.
    Hausner RS
    J Clin Psychiatry; 1983 Jan; 44(1):13-6. PubMed ID: 6130081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.